Skip to main content

First Tracks Biotherapeutics, Inc S-1, filed Oct 26, 2026

First Tracks Biotherapeutics, Inc. (TRAX)

First Tracks Biotherapeutics registered 6,106,870 common shares for resale after a private placement at $32.75 per share, closed October 19, 2026, generated approximately $200 million in proceeds. The company will receive no proceeds from the sale. AI summary

S-1 2026-10-26
View Original
Added on October 26, 2026